A detailed history of Ubs Asset Management Americas Inc transactions in Optimize Rx Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 310,000 shares of OPRX stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
310,000
Previous 310,000 -0.0%
Holding current value
$1.37 Million
Previous $3.1 Million 22.81%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$8.8 - $13.17 $2.73 Million - $4.08 Million
310,000 New
310,000 $3.1 Million
Q1 2022

May 16, 2022

SELL
$35.27 - $62.91 $179,101 - $319,456
-5,078 Reduced 38.07%
8,262 $311,000
Q4 2021

Feb 14, 2022

BUY
$53.57 - $98.0 $177,048 - $323,890
3,305 Added 32.93%
13,340 $828,000
Q3 2021

Nov 15, 2021

BUY
$50.93 - $85.55 $11,866 - $19,933
233 Added 2.38%
10,035 $858,000
Q2 2021

Aug 16, 2021

BUY
$42.76 - $63.33 $419,133 - $620,760
9,802 New
9,802 $606,000

Others Institutions Holding OPRX

About OptimizeRx Corp


  • Ticker OPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 18,023,100
  • Market Cap $79.7M
  • Description
  • OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...
More about OPRX
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.